<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Minutes of the Monthly MODVAT meeting held on 6-2-1989 and 8-3-1989 at Delhi - Point No. 15 - Regarding Modvat problem concerning pharmaceutical products</title>
    <link>https://www.taxtmi.com/circulars?id=6683</link>
    <description>Credit of duty taken on inputs that are in stock on the date the finished product becomes exempt must be reversed because those inputs will be used in exempt final products; Rule 57C is sufficiently clear to require such reversal and needs no amendment, and field formations and trade are to be informed so pending cases may be settled accordingly.</description>
    <language>en-us</language>
    <pubDate>Fri, 30 Jun 1989 00:00:00 +0530</pubDate>
    <lastBuildDate>Sat, 04 Jul 2009 16:07:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=260950" rel="self" type="application/rss+xml"/>
    <item>
      <title>Minutes of the Monthly MODVAT meeting held on 6-2-1989 and 8-3-1989 at Delhi - Point No. 15 - Regarding Modvat problem concerning pharmaceutical products</title>
      <link>https://www.taxtmi.com/circulars?id=6683</link>
      <description>Credit of duty taken on inputs that are in stock on the date the finished product becomes exempt must be reversed because those inputs will be used in exempt final products; Rule 57C is sufficiently clear to require such reversal and needs no amendment, and field formations and trade are to be informed so pending cases may be settled accordingly.</description>
      <category>Circulars</category>
      <law>Central Excise</law>
      <pubDate>Fri, 30 Jun 1989 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/circulars?id=6683</guid>
    </item>
  </channel>
</rss>